ArticleBlood cell therapy2023

Gilteritinib in peritransplant period for relapsed or refractory FLT3-mutated acute myeloid leukemia: A case report of three patients.

Fuka Mima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.